All data are based on the daily closing price as of April 28, 2025
t
Towa Pharmaceutical
4553.TSE
18.30 USD
0.03
+0.16%
Overview
Last close
18.30 usd
Market cap
901.03M usd
52 week high
21.55 usd
52 week low
15.68 usd
Target price
26.9 usd
Valuation
P/E
6.6845
Forward P/E
16.7785
Price/Sales
0.5122
Price/Book Value
0.7625
Enterprise Value
2.25B usd
EV/Revenue
1.2753
EV/EBITDA
10.6162
Key financials
Revenue TTM
1.77B usd
Gross Profit TTM
639.28M usd
EBITDA TTM
289.18M usd
Earnings per Share
2.73 usd
Dividend
0.42 usd
Total assets
2.94B usd
Net debt
1.24B usd
About
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.